Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naive Thai patients with atrial fibrillation (TREATS-AF): a study protocol



Phrommintikul, Arintaya, Nathisuwan, Surakit, Gunaparn, Siriluck, Krittayaphong, Rungroj, Wongcharoen, Wanwarang, Sehmi, Sukhi, Mehta, Samir, Winkles, Neil, Brocklehurst, Peter, Mathers, Jonathan
et al (show 5 more authors) (2021) Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naive Thai patients with atrial fibrillation (TREATS-AF): a study protocol. BMJ OPEN, 11 (10). e051987-. ISSN 2044-6055, 2044-6055

[thumbnail of Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therap.pdf] Text
Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therap.pdf - Published version

Download (752kB) | Preview

Abstract

<h4>Introduction</h4>The burden of atrial fibrillation (AF) in Thailand is high and associated with increased morbidity, mortality and healthcare costs. Vitamin K antagonists (eg, warfarin), commonly used for stroke prevention in patients with AF in Thailand, are effective but are often suboptimally controlled. We aim to evaluate the impact of an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy and educational intervention compared to usual care on anticoagulation control expressed by the time in therapeutic range (TTR) at 12 months, in anticoagulant-naïve Thai patients with AF.<h4>Methods and analysis</h4>Multicentre, open-label, parallel-group, randomised controlled trial conducted in Thailand among adult patients (age: 18 years) with AF who are anticoagulant naïve. Patients will be randomised to one of two groups; an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy with educational intervention and usual care versus usual care alone. The planned follow-up period is 12 months. The primary outcome is TTR at 12 months. Secondary outcomes include: (1) TTR at 6 months; (2) thromboembolic and bleeding events at 12 months; (3) composite major adverse cardiovascular events at 12 months; (4) change in patients' knowledge of AF between baseline and 6 months and 12 months; (5) cost effectiveness; (6) quality of life at baseline, 6 months and 12 months using EQ-5D-5L (Thai version) and (7) patient satisfaction/perceptions of the TREAT intervention. An embedded qualitative study will assess patient perceptions of the TREAT intervention.<h4>Ethics and dissemination</h4>The study has been approved by the Ethical Review Committee, Ministry of Public Health of Thailand, and registered in the Thai Clinical Trials Registry. The results of this trial will be submitted for publication in a peer-reviewed journal. Participants will be informed via a link to a preview of the publication. A lay summary will also be provided to all participants prior to publication.<h4>Trial registration number</h4>TCTR20180711003.

Item Type: Article
Uncontrolled Keywords: cardiology, qualitative research, health economics
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 20 Dec 2021 16:31
Last Modified: 06 Dec 2024 19:47
DOI: 10.1136/bmjopen-2021-051987
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3145711